KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.91 $2.61 Friday, 26th Apr 2024 CHRS stock ended at $2.04. This is 5.70% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.74% from a day low at $1.93 to a day high of $2.06.
90 days $1.91 $2.87
52 weeks $1.44 $8.22

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Oct 29, 2021 $16.60 $16.96 $16.38 $16.73 454 570
Oct 28, 2021 $16.18 $16.74 $16.12 $16.68 376 822
Oct 27, 2021 $16.45 $16.49 $16.05 $16.07 500 491
Oct 26, 2021 $16.76 $16.84 $16.38 $16.40 334 342
Oct 25, 2021 $16.70 $16.82 $16.54 $16.72 238 952
Oct 22, 2021 $16.62 $16.82 $16.35 $16.79 332 183
Oct 21, 2021 $16.58 $16.88 $16.31 $16.68 674 811
Oct 20, 2021 $17.07 $17.12 $16.50 $16.59 309 662
Oct 19, 2021 $17.24 $17.28 $16.94 $17.15 265 085
Oct 18, 2021 $16.80 $17.12 $16.62 $17.06 485 183
Oct 15, 2021 $17.63 $17.66 $16.95 $17.00 524 306
Oct 14, 2021 $17.72 $17.91 $17.44 $17.49 329 504
Oct 13, 2021 $17.60 $17.77 $17.43 $17.48 227 662
Oct 12, 2021 $17.75 $17.75 $17.23 $17.52 310 370
Oct 11, 2021 $17.60 $18.05 $17.47 $17.74 470 561
Oct 08, 2021 $17.56 $18.13 $17.55 $18.04 445 948
Oct 07, 2021 $16.66 $17.61 $16.64 $17.60 654 824
Oct 06, 2021 $16.09 $16.70 $15.89 $16.59 551 644
Oct 05, 2021 $15.85 $16.57 $15.73 $16.17 874 320
Oct 04, 2021 $16.53 $16.75 $15.75 $15.81 639 217
Oct 01, 2021 $16.19 $16.74 $15.91 $16.52 1 002 166
Sep 30, 2021 $16.29 $16.68 $16.02 $16.07 843 196
Sep 29, 2021 $16.91 $17.41 $16.05 $16.46 982 233
Sep 28, 2021 $17.62 $17.62 $16.82 $16.89 749 868
Sep 27, 2021 $17.92 $18.21 $17.76 $17.79 713 497
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT